Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
71 2.7% |
 |
Eli Lilly and CompanyLLY |
83 0% |
 |
PfizerPFE |
53 1.9% |
 |
AstrazenecaAZN |
82 0% |
 |
AbbVieABBV |
77 1.3% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 67 | |
| Sep 2024 | 72 | |
| Aug 2024 | 66 | |
| Jul 2024 | 66 |
How do employees feel about the future at Esperion Therapeutics?
The Business Outlook at Esperion Therapeutics is positive according to its employees. The average outlook rating 69 (out of 100) is high. This rating, aggregated from the top review sites in the US, is also up by 3% since the last month.
Analyzing Business Outlook, how is Esperion Therapeutics performing compared to its industry peers?
Esperion Therapeutics overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 69th percentile.
How has the business outlook at Esperion Therapeutics changed over the last couple of months
In recent months, Esperion Therapeutics' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Esperion Therapeutics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Esperion Therapeutics.
